Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02722746 · ClinicalTrials.gov registry record · Phase 1
The Prevention of Hypotension After Epidural Analgesia After Major Surgery
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 66
- Enrollment target
NCT02722746 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 66 participants.
The verdict
NCT02722746, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 66 participants
- Enrollment target
Study Summary
Epidural analgesia via continuous epidurally infused local anesthetic agent (LA) is widely and very successfully used routinely for perioperative pain control in patients undergoing major orthopedic and abdominal surgery since 1928. The choice currently depends on the preference of the APS physician in charge of the case. A frequent unwanted side effect of epidural block is hypotension due to the epidurally injected LA blocking the sympathetic nerves and thus the patient's response to hypotension, which is usually due to hypovolemia and/or an unopposed parasympathetic (via the vagus nerve) nervous system. The purpose of this research study is to see if adding epinephrine, to the epidural anesthetic will decrease possible side effects, such as low blood pressure, and lead to a better effect of the epidural anesthetic.
Interventions
- DRUG Epinephrine
- DRUG Ropivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2016-11-15 |
| Est. Completion | 2018-09-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02722746
The ClinicalTrials.gov registry entry for NCT02722746 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Epinephrine is the first listed.
NCT02722746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02722746 about?
NCT02722746 is a clinical study titled "The Prevention of Hypotension After Epidural Analgesia After Major Surgery". Epidural analgesia via continuous epidurally infused local anesthetic agent (LA) is widely and very successfully used routinely for perioperative pain control in patients undergoing major orthopedic and abdominal surgery since 1928. The choice currently depends on the preference of the APS physician...
What is the current status of trial NCT02722746?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 66 participants. The study started on 2016-11-15. Estimated completion is 2018-09-14.
What interventions are being tested in trial NCT02722746?
The interventions under investigation include: Epinephrine (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT02722746?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.